These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21193654)

  • 1. Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis.
    Vaa BE; Asrani SK; Dunn W; Kamath PS; Shah VH
    Mayo Clin Proc; 2011 Jan; 86(1):37-42. PubMed ID: 21193654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MELD accurately predicts mortality in patients with alcoholic hepatitis.
    Dunn W; Jamil LH; Brown LS; Wiesner RH; Kim WR; Menon KV; Malinchoc M; Kamath PS; Shah V
    Hepatology; 2005 Feb; 41(2):353-8. PubMed ID: 15660383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.
    Kim JJ; Kim JH; Koo JK; Choi YJ; Ko SY; Choe WH; Kwon SY
    Clin Mol Hepatol; 2014 Mar; 20(1):47-55. PubMed ID: 24757658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model for end-stage liver disease score versus Maddrey discriminant function score in assessing short-term outcome in alcoholic hepatitis.
    Kadian M; Kakkar R; Dhar M; Kaushik RM
    J Gastroenterol Hepatol; 2014 Mar; 29(3):581-8. PubMed ID: 24117536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt.
    Guy J; Somsouk M; Shiboski S; Kerlan R; Inadomi JM; Biggins SW
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1236-40. PubMed ID: 19560557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of MELD-Na versus MELDNa in the prediction of short-term prognosis for acute-on-chronic hepatitis B liver failure].
    He WP; Hu JH; Tong JJ; Liu FF; Wang HF
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1173-7. PubMed ID: 21756769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis.
    Hsu CY; Lin HC; Huang YH; Su CW; Lee FY; Huo TI; Lee PC; Lee JY; Lee SD
    Dig Liver Dis; 2010 Feb; 42(2):137-42. PubMed ID: 19595648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites.
    Sersté T; Gustot T; Rautou PE; Francoz C; Njimi H; Durand F; Valla D; Lebrec D; Moreau R
    J Hepatol; 2012 Aug; 57(2):274-80. PubMed ID: 22521353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
    Morales-Arráez D; Ventura-Cots M; Altamirano J; Abraldes JG; Cruz-Lemini M; Thursz MR; Atkinson SR; Sarin SK; Kim W; Chavez-Araujo R; Higuera-de la Tijera MF; Singal AK; Shah VH; Kamath PS; Duarte-Rojo A; Charles EA; Vargas V; Jager M; Rautou PE; Rincon D; Zamarripa F; Restrepo-Gutiérrez JC; Torre A; Lucey MR; Arab JP; Mathurin P; Louvet A; García-Tsao G; González JA; Verna EC; Brown RS; Argemi J; Fernández-Carrillo C; Clemente A; Alvarado-Tapias E; Forrest E; Allison M; Bataller R
    Am J Gastroenterol; 2022 Feb; 117(2):301-310. PubMed ID: 34962498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascites improves upon [corrected] serum sodium plus [corrected] model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease.
    Somsouk M; Guy J; Biggins SW; Vittinghoff E; Kohn MA; Inadomi JM
    Aliment Pharmacol Ther; 2009 Oct; 30(7):741-8. PubMed ID: 19604177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].
    Li JY; Deng Q; Wang Y; Xu MY; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):896-901. PubMed ID: 23522249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.
    Myers RP; Tandon P; Ney M; Meeberg G; Faris P; Shaheen AA; Aspinall AI; Burak KW
    Liver Int; 2014 Sep; 34(8):1176-83. PubMed ID: 24256642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis.
    Fernandes SR; Marques da Costa P; Vítor S; Carvalho JR; Santos P; Moura CM; Cortez-Pinto H; Ramalho F; Velosa J
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1141-1148. PubMed ID: 28628497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events.
    Verma S; Ajudia K; Mendler M; Redeker A
    Dig Dis Sci; 2006 Sep; 51(9):1637-43. PubMed ID: 16927139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India.
    Daswani R; Kumar A; Anikhindi SA; Sharma P; Singla V; Bansal N; Arora A
    Indian J Gastroenterol; 2018 Mar; 37(2):141-152. PubMed ID: 29704174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis.
    Sheth M; Riggs M; Patel T
    BMC Gastroenterol; 2002; 2():2. PubMed ID: 11835693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different models in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.
    Yang WB; Chen EQ; Bi HX; Bai L; Chen XB; Feng P; Tang H
    Ann Hepatol; 2012; 11(3):311-9. PubMed ID: 22481448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of MELD3.0 in 2 centers from different continents.
    Tejedor M; Bellón JM; Fernández de la Varga M; Peralta P; Montalvá E; Selzner N; Berenguer M
    Hepatol Commun; 2024 Aug; 8(8):. PubMed ID: 39082971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life is dynamic in alcoholic hepatitis and responds to improvement in liver disease and reduced alcohol consumption.
    Madathanapalli A; Tang Q; Lammert C; Samala N; Shah VH; Sanyal A; Chalasani N; Desai AP
    Alcohol Clin Exp Res; 2022 Feb; 46(2):252-261. PubMed ID: 34862610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.